# clm_F959576F5D57

subject: Amgen (/record/amgen.md)  
predicate: total_equity  
value: 21,728,000,000 United States dollar  
valid_from: 2013-09-30  
valid_to: 2013-12-31  
published: 2013-10-29  
recorded: 2026-11-08  
confidence: 0.95  
status: superseded  
assertable: true  
superseded_by: clm_CC7EBB14F5AA  
last_updated: 2026-11-08  
cite: AsOf. "Amgen total equity: 21,728,000,000 United States dollar", as of 2013-09-30 (until 2013-12-31). Claim clm_F959576F5D57, https://asof.is/claim/clm_F959576F5D57, accessed 2026-11-09. Source: https://www.sec.gov/Archives/edgar/data/318154/000031815413000012/0000318154-13-000012-index.htm.  
checked: 2026-11-08 · parsed from the SEC filing  
parsed from: us-gaap:StockholdersEquity in 10-Q Q3 FY2013, filed 2013-10-29  

## Sources

- https://www.sec.gov/Archives/edgar/data/318154/000031815413000012/0000318154-13-000012-index.htm (primary, SEC EDGAR 10-Q Q3 FY2013, published 2013-10-29)

## Supersedes

- [Amgen](/record/amgen.md) | total_equity | 20,594,000,000 United States dollar | valid 2013-06-30 to 2013-09-30 | conf 0.95 | superseded | superseded_by [clm_F959576F5D57](/claim/clm_F959576F5D57.md) | [clm_D15F50A325E7](/claim/clm_D15F50A325E7.md)

---

AsOf is a temporal fact ledger: a structured, dated, sourced record of what is true and what changed, built for AI retrieval.